BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29466990)

  • 1. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
    Alric C; Hervé-Aubert K; Aubrey N; Melouk S; Lajoie L; Même W; Même S; Courbebaisse Y; Ignatova AA; Feofanov AV; Chourpa I; Allard-Vannier E
    J Nanobiotechnology; 2018 Feb; 16(1):18. PubMed ID: 29466990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
    Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
    Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
    J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
    Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
    Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
    Sano K
    Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
    Li X; Xia S; Zhou W; Ji R; Zhan W
    Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells.
    Vigor KL; Kyrtatos PG; Minogue S; Al-Jamal KT; Kogelberg H; Tolner B; Kostarelos K; Begent RH; Pankhurst QA; Lythgoe MF; Chester KA
    Biomaterials; 2010 Feb; 31(6):1307-15. PubMed ID: 19889453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer.
    Cheng YA; Wu TH; Wang YM; Cheng TL; Chen IJ; Lu YC; Chuang KH; Wang CK; Chen CY; Lin RA; Chen HJ; Liao TY; Liu ES; Chen FM
    J Nanobiotechnology; 2020 Aug; 18(1):118. PubMed ID: 32854720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
    Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
    Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
    Zolata H; Abbasi Davani F; Afarideh H
    Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.
    Chen Y; Wang W; Lian G; Qian C; Wang L; Zeng L; Liao C; Liang B; Huang B; Huang K; Shuai X
    Int J Nanomedicine; 2012; 7():359-68. PubMed ID: 22848158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging.
    Kim HY; Wang X; Wahlberg B; Edwards WB
    Bioconjug Chem; 2014 Jul; 25(7):1311-22. PubMed ID: 24898150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.
    Bruniaux J; Allard-Vannier E; Aubrey N; Lakhrif Z; Ben Djemaa S; Eljack S; Marchais H; Hervé-Aubert K; Chourpa I; David S
    Int J Pharm; 2019 Oct; 569():118572. PubMed ID: 31352052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
    Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Human Epidermal Growth Factor Receptor 2 Single-Chain Fv Fragment-Decorated DM1 Nanoparticles for Specific Targeting of Human Epidermal Growth Factor Receptor 2-Positive Breast Tumor Cells.
    Ni L; Li YX
    J Biomed Nanotechnol; 2021 Mar; 17(3):447-455. PubMed ID: 33875079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.